A 6-month phase 3, multicenter, prospective, randomized, double-blind, vehicle-controlled study, to evaluate the efficacy and safety of topically applied clascoterone (cortexolone 17a-propionate) solution for the treatment of androgenetic alopecia in mal

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences